Regeneron earns a buy rating with strong profit margins, low debt, and growth potential. Discover why shares may see a 39% ...

Deutsche Bank AG boosted its stake in Regeneron Pharmaceuticals by nearly 22% in Q4, now holding 539,269 shares valued at ...

We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where ...

We recently compiled a list of the 10 Jim Cramer Stocks with Huge Upside Potential. In this article, we are going to take a ...

We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

Schonfeld Strategic Advisors made a bold biotech play by boosting its Regeneron holdings by over 475% in Q4. The firm added ...

REGN's trading volume is 167,455 compared to the stock's average volume of 1,044,709 ... and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and ...

Shares of Regeneron Pharmaceuticals Inc. REGN advanced 5.25% to $598.76 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX ...

Following the announcement, Regeneron’s stock price fell by 8.19% in pre-market trading, reflecting investor disappointment. This performance aligns with recent analyst sentiment, as InvestingPro data ...

Regeneron's performance in the first quarter was dismal ... NVIDIA is still strong, but our new top chip stock has much more room to boom. With strong earnings growth and an expanding customer ...